AESG - ETF AI Analysis
Top Page
Harbor AlphaEdge Small Cap Growth ETF (AESG)
AESG, the Harbor AlphaEdge Small Cap Growth ETF, has a solid overall rating driven mainly by strong, growth-focused holdings like Harmony Biosciences and Abercrombie & Fitch, which show robust financial performance, positive earnings calls, and attractive valuations. Other contributors such as First Bancorp Puerto Rico and LiveRamp add to the fund’s quality through strong revenue growth and strategic initiatives, though some holdings face issues like high leverage, overbought technical signals, or valuation risks. The main risk factor is that several top positions share similar concerns around leverage and potentially stretched valuations, which could increase volatility for investors.
AESG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.96M
- Region
- North America
- Expense Ratio
- 0.40%
- Beta
- 1.09
- Issuer
- Harbor
- Inception Date
- Aug 26, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
AESG Summary
Harbor AlphaEdge Small Cap Growth ETF (AESG) is an exchange-traded fund that focuses on fast-growing smaller U.S. companies, without tracking a specific index. It mainly invests in areas like health care, technology, and industrials, and holds names such as Cheesecake Factory and Apple Hospitality REIT. Someone might consider AESG if they want long-term growth and diversification into small-cap stocks that could grow faster than larger, more established companies. However, because it concentrates on smaller, growth-focused businesses, its price can be more volatile and may rise or fall more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.40%, which means you’ll pay about $4 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and focuses on a specialized small-cap growth strategy, which typically costs more to run than broad, passive index funds.
What would affect this ETF?
AESG could benefit if the U.S. economy stays healthy, consumer spending remains solid, and innovation in health care and technology continues, supporting growth for its small, fast-growing companies and top holdings in finance, biotech, and consumer businesses. On the downside, rising interest rates, tighter credit conditions, or an economic slowdown would typically hurt small-cap growth stocks more than larger, steadier companies, and sector-specific risks in health care regulation, technology competition, or real estate could add extra volatility.
AESG Top 10 Holdings
AESG is leaning into U.S. small-cap growth with a quirky mix of health care, tech, financials, and consumer names. Retail and dining are doing the heavy lifting: Abercrombie Fitch has been sprinting higher, while Cheesecake Factory has quietly become a standout, giving the fund a consumer-driven tailwind. On the financial side, Bread Financial and Slide Insurance are rising, though Enova’s more mixed trend has been a mild drag. In health care, Protagonist Therapeutics is climbing but Harmony Biosciences has lost some steam lately, adding a bit of volatility to the ride.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 APLE | Apple Hospitality REIT | 3.06% | $60.01K | $4.37B | 62.46% | 64Neutral |
 BFH | Bread Financial Holdings | 2.67% | $52.20K | $3.93B | 67.03% | 72Outperform |
 RAMP | LiveRamp Holdings | 2.57% | $50.39K | $2.34B | 40.87% | 75Outperform |
 SLDE | Slide Insurance Holdings, Inc. | 1.98% | $38.83K | $3.25B | 75.17% | 73Outperform |
 FBP | First Bancorp Puerto Rico | 1.82% | $35.72K | $3.95B | 34.39% | 76Outperform |
 CAKE | Cheesecake Factory | 1.73% | $33.82K | $5.61B | 129.36% | 66Neutral |
 PTGX | Protagonist Therapeutics | 1.70% | $33.20K | $9.37B | 86.06% | 68Neutral |
 ANF | Abercrombie Fitch | 1.57% | $30.83K | $6.98B | 127.69% | 78Outperform |
 HRMY | Harmony Biosciences Holdings | 1.55% | $30.45K | $2.26B | 34.12% | 81Outperform |
 VCTR | Victory Capital Holdings | 1.55% | $30.27K | $6.85B | 78.77% | 80Outperform |
AESG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AESG, the sentiment is Negative. The current price of 19.06 is below the 20-day moving average (MA) of 19.28, compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 45.14 is Neutral, neither overbought nor oversold. The STOCH value of 76.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AESG.
AESG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| AESG | $19.06 | $20.50(7.58% Upside) | $1.96M | 0.40% | 66Neutral |
 ACSG | $45.80 | $62.97(37.49% Upside) | $54.55M | 0.49% | 64Neutral |
 TMFS | $34.02 | $44.54(30.91% Upside) | $53.41M | 0.85% | 63Neutral |
 MMSC | $26.45 | $34.26(29.52% Upside) | $53.09M | 0.95% | 63Neutral |
 SGRW | $24.07 | $35.36(46.89% Upside) | $28.11M | 0.80% | 60Neutral |
 FSEG | $25.81 | $36.23(40.35% Upside) | $7.92M | 0.28% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AESG | Harbor AlphaEdge Small Cap Growth ETF | 19.06 | -1.06 | -5.27% | |
| ACSG | American Century Small Cap Growth Insights ETF | 45.80 | 5.01 | 12.27% | |
| TMFS | Motley Fool Small-Cap Growth ETF | 34.02 | 0.11 | 0.32% | |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 26.45 | 2.17 | 8.92% | |
| SGRW | Harbor Active Small Cap Growth ETF | 24.07 | 3.78 | 18.61% | |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 25.81 | 0.58 | 2.31% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.